The companion diagnostics market is becoming increasingly important as healthcare moves from broad treatment approaches toward precision medicine and biomarker-guided therapies. The market was valued at USD 9.6 billion in 2025 and is projected to grow from USD 10.3 billion in 2026 to USD 20.1 billion by 2033, registering a CAGR of 10.1% from 2026 to 2033. Increasing demand for precision...